Adlai Nortye (ANL) Notes Payables (2022 - 2025)
Adlai Nortye (ANL) posted quarterly Notes Payables of $24.6 million for Q4 2025, down 6.64% year-over-year from $26.3 million in Q4 2024, and down 6.64% quarter-over-quarter from $26.3 million in Q4 2024.
Analysis
Adlai Nortye (ANL) Notes Payables (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has reported Notes Payables for 4 consecutive years, with $24.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Notes Payables fell 6.64% year-over-year to $24.6 million; the TTM figure through Dec 2025 stood at $24.6 million (down 6.64% YoY), while the FY2025 annual figure was $24.6 million, down 6.64% from the prior year.
- Notes Payables fell to $24.6 million in Q4 2025 per ANL's latest filing, from $26.3 million in the prior quarter.
- Across five years, Notes Payables topped out at $30.4 million in Q4 2023 and bottomed at $4.3 million in Q4 2022.
- Historically, Notes Payables has averaged $21.4 million across 4 years, with a median of $25.5 million in 2024.
- Annual changes were most pronounced in 2023 — Notes Payables soared 604.83% — and 2024, when it fell 13.27%.
- Adlai Nortye's Notes Payables stood at $4.3 million in 2022, then jumped by 604.83% to $30.4 million in 2023, then fell by 13.27% to $26.3 million in 2024, then dropped by 6.64% to $24.6 million in 2025.
- Business Quant data shows ANL's Notes Payables at $24.6 million in Q4 2025, $26.3 million in Q4 2024, and $30.4 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Adlai Nortye | 500.08 Mn | 268.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 24.58 Mn |
| Dec 31, 2024 | 26.33 Mn |
| Dec 31, 2023 | 30.36 Mn |
| Dec 31, 2022 | 4.31 Mn |